NEW YORK (GenomeWeb News) – Sigma-Aldrich said today that it will make and market oligonucleotides developed by Polyplus-transfection, a Strasbourg, France-based firm, under a new worldwide license agreement.

The agreement covers Polyplus-transfection's Zip Nucleic Acid (ZNA) oligonucleotides, which are designed for use in research and diagnostic applications.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.